E-MED: 2003 SEAM Conference
---------------------------------------------------------------------
[Mod�rateur: voici le programme d'une conf�rence sur les politiques
pharmaceutiques en Afrique qui devrait r�unir en Tanzanie la semaine plus de
400 participants (dont quelques francophones) et dont un des objectifs est
d'�mettre des recommandations...CB]
� Cibler l�acc�s �largi, � le 10-12 D�cembre 2003,
Dar es Salaam, R�publique unie de Tanzanie
avec le Minist�re de la Sant� de la R�publique unie de Tanzanie, le
D�partement des m�dicaments essentiels et politique pharmaceutique de l�
Organisation mondiale de la Sant�, la Fondation Rockefeller, le R�seau
international pour l�utilisation rationnelle des m�dicaments (INRUD), et les
Programmes Rational Pharmaceutical Management Plus (financ� par l�Agence des
Etats-Unis pour le D�veloppement international) et SEAM de Management
Sciences for Health (MSH).
La Conf�rence 2003 assemblera les d�positaires principaux pour discuter des
mani�res d'avancer l'acc�s aux m�decines essentielles dans les pays en voie
de d�veloppement, d'adresser les soucis de la fourniture pharmaceutique et
de l'�valuation, et d'assurer les syst�mes de gestion pharmaceutiques
efficaces. La Conf�rence fournira �galement l'occasion de partager des
informations sur les activit�s de plusieurs initiatives de SEAM et d'autres
projets qui se concentrent sur l'acc�s croissant aux m�decines essentielles.
La Conf�rence est particuli�rement opportune � cause de plus grand
�coulement du fonds par le Fonds mondial de lutte contre le SIDA, la
tuberculose et le paludisme, comme d'autres efforts d'am�liorer l'acc�s aux
m�decines.
La conf�rence comportera des pr�sentations pl�ni�res et des pr�sentations
parall�les sur six mati�res principales, suivies des discussions en table
ronde pour chaque mati�re. Les pr�sentations de posters pourvoiront une
occasion pour les participants pr�senter sur leurs initiatives, recherche,
et exp�rience.
website de la Conf�rence (www.msh.org/seam/conference)
Programme
Conference SEAM 2003
DAY 1�December 10, 2003
All Day
Posters and electronic demos on display
Author coverage during breaks
8:30�10:00 a.m.
Morning session #1
Plenary presentations � Room: Kivukoni 1-3 (Simultaneous French translation
available)
� Welcoming remarks
Jim Rankin, Management Sciences for Health, U.S.A.
� Video message from the Bill & Melinda Gates Foundation
Dr. Richard D. Klausner, M.D., Executive Director, Global Health
� Introduction of dignitaries
Dr. Gabriel Upunda, Chief Medical Officer, Ministry of Health, United
Republic of Tanzania
� Commonwealth Regional Health Community remarks
Dr. Steven Shongwe, Regional Secretary, Commonwealth Regional Health
Community
� Remarks by Representative of Health Ministers
To be announced
� Rapid Expansion of Access to ARVs � The Litmus Test of Drug Management for
the 21st Century
Dr. Jack Chow, Assistant Director-General, World Health Organization
� Welcoming the Guest of Honor
Honorable Anna Margareth Abdallah, Minister of Health, United Republic of
Tanzania
� Opening address
Amani Karume, President, Zanzibar, United Republic of Tanzania
� Closing remarks
Jim Rankin, Management Sciences for Health, U.S.A.
10:00�10:30 a.m.
Coffee/Tea break
10:30 a.m.�12:30 p.m.
Morning session #2
Moderator: Jim Rankin, Management Sciences for Health, USA
Plenary presentations � Room: Kivukoni 1-3 (Simultaneous French translation
available)
� Overview of Pharmaceutical Access Issues in Developing Countries
Peter Mugyenyi, Joint Clinical Research Center, Uganda
� The Mombasa Initiative: Developing and Implementing an Antiretroviral
Therapy Program in Kenya
Michael Thuo, Management Sciences for Health/RPM Plus, Nairobi, Kenya
� Does the Public Sector Reach the Poor?
Ndola Prata, School of Public Health, University of California, Berkeley,
U.S.A.
� The Role of the Private Sector in Public Supply of Medicines
Evan Lee and Denis Broun, Management Sciences for Health Europe,
Ferney-Voltaire, France
� Discussion
12:30 p.m.�1:30 p.m.
Lunch break
1:30�3:30 p.m.
Afternoon session #1
Parallel track sessions
Pharmaceutical Management and Supply Systems � Room: Kivukoni 4
Co-moderators: Margareth Ndomondo-Sigonda and Nancy Blum
1. Public Health Supply Systems � An Overview
Malcolm Clark, Management Sciences for Health/SEAM, U.S.A.
2. Essential Drug Franchises
a. Experience with Community Health Workers in Kenya
Liza Kimbo, SHEF, Kenya
b. Developing a Chemical Sellers� Franchise in Ghana
Alex Banful, GSMF, Ghana
3. Improving Access to Medicines in Rural Areas: The Tanzanian Experience
Romuald Mbwasi, SEAM/Tanzania
4. Community Health Workers in Senegal Treat ARI with Co-trimoxazole
Emmanuel Wansi, BASICS II, U.S.A.
5. Public Sector Supply in a Decentralized Environment: The Experience in
South Africa
Mandisa Hela, Ministry of Health, Department of Drugs, South Africa
6. Pharmaceutical Industry Supply Initiatives: Lessons Learned
Sowedi Muyingo, Axios International
Rational Use of Medicines � Room: Kivukoni 1-3 (Simultaneous French
translation available)
Co-moderators: Amos Massele and John Chalker
1. Improving Use of Medicines in the Era of Expanding Access: Public and
Private Sector Approaches
Dennis Ross-Degnan, Harvard University, Boston, U.S.A.
2. Evidence-Based Drug Decision Making: An International Collaborative
Framework
Gavin Steel, South Africa
3. Current Approaches to Selection of Essential Drugs and Treatment
Guidelines: Indian Experiences
Sangeeta Sharma, Delhi Society for Promoting Rational Use of Drugs, India
4. Community Drug Use Assessments: How Are They Done and How Useful Are They
in Promoting Rational Use of Medicines
a. Community Drug Use Assessments: Methodological Issues in Design,
Implementation, and Using Results to Promote Rational Drug Use
Michael Gabra, Management Sciences for Health/RPM Plus, U.S.A.
b. Community Drug Use Assessments: Experience from Senegal
Issa Diop, Ministry of Health, Central Medical Stores, Senegal
5. Antimicrobial Resistance and Rational Use: The Challenges Ahead
Mohan Joshi, Management Sciences for Health/RPM Plus, U.S.A.
6. Role of Regulatory Authorities in Promoting Rational Use of Drugs
Sauwakon Ratanawijitrasin, Chulalongkorn University, Thailand
3:30�4:00 p.m.
Coffee/Tea break
4:00�6:00 p.m.
Afternoon session #2
Small group discussions
Pharmaceutical Management
and Supply Systems
Group A � Room: Ruvu
Group B � Room: Kivukoni 4
Group C � Room: Marquee 3
Group D � Room: Marquee 4
Rational Use of Medicines
Group A � Room: Marquee 1
Group B � Room: Marquee 2
Group C � Room: Tradewinds
Group D � Room: Kivukoni 1-3
DAY 2�December 11, 2003
All Day
Posters and electronic demos on display
Author coverage during breaks
8:30�10:00 a.m.
Morning session #1
Moderator: Gabriel Upunda
Plenary presentations � Room: Kivukoni 1-3 (Simultaneous French translation
available)
� The Evolving Role of Pharmaceutical Assessments: A USAID Perspective
Anthony Boni, USAID
� Effective Drug Regulation in the Real World
Moderator: Lembit R�go, WHO/EDM
� Overview of the Issues
Sauwakon Ratanawijitrasin, Thailand
� Developing Country Perspectives
o Human and Financial Resources
Margareth Ndomondo-Sigonda, Food and Drugs Authority, Tanzania
o Harmonization in the SADC Region: Challenges of Information Exchange
Precious Matsoso, Ministry of Health, Department of Drugs, South Africa
o The Four P�s of Drug Product Quality
Benjamin Botwe, Food and Drugs Board, Ghana
10:00�10:30 a.m.
Coffee/Tea break
10:30 a.m.�12:30 p.m.
Morning session #2
Moderator: Gabriel Upunda
Plenary presentations � Room: Kivukoni 1-3 (Simultaneous French translation
available)
� Medicine Pricing: What�s Happening, and Where Do We Go from Here?
Jonathan Quick, WHO/EDM
� Financing Drug Procurement: The Global Fund to Fight AIDS, Tuberculosis
and Malaria
Guido Bakker, GFATM, Switzerland
� Monitoring Access to Essential Medicines
1. The Developing Country Perspective and Experience
Joseph Serutoke, Uganda
2. Measures and Methods
David Lee, Management Sciences for Health/CPM, U.S.A.
� Discussion
12:30 p.m.�1:30 p.m.
Lunch break
1:30�3:30 p.m.
Afternoon session #1
Parallel track sessions
Pharmaceutical Procurement � Room: Kivukoni 1-3 (Simultaneous French
translation available)
Co-moderators: Joseph Muhume and Anthony So
1. Overview of Pooled Procurement Models
Andrew Barraclough, Management Sciences for Health/M&L, Indonesia
2. Critical Success Factors for Pooled Procurement
Francis Burnett, OECS/PPS, St. Lucia
3. Enhancing Access to Treatment for PLWHA in the ECSA Region: Activities of
the Commonwealth Regional Health Community
Bannet Ndyanabangi, CRHCS, Tanzania
4. Lessons Learned from MSF Experience in ARV Procurement in Developing
Countries
Raffaella Ravinetto, M�decins sans Fronti�res, Spain
5. Development and Testing of a Prequalification Procedure for HIV/AIDS, TB,
and Malaria Products and Manufacturers
Lembit R�go, WHO/EDM
6. Integration of Vertical Disease-Related Procurement Systems into
Mainstream Procurement Efforts
Christopher Msemo, Medical Stores Department, Tanzania
Human Resources for the Pharmaceutical Sector � Room: Kivukoni 4
Co-moderators: G. Mliga and Douglas Keene
1. Human Resources for the Pharmaceutical Sector: Issues, Challenges, and
Opportunities
Eva Ombaka, EPN, Kenya
2. Employment Opportunities, Career Development, and Preventing �Brain
Drain�
Mabel Torongo, Zimbabwe
3. Human Capacity Development as an Effective Response to HIV/AIDS: Human
Resources Implications of Scaling Up Care
Ummuro Adano, Management Sciences for Health/M&L, Kenya
4. Using Best Practices to Improve Performance
Nina Pruyn, Advance Africa, U.S.A.
5. Community-Based Training of Informal Drug Sellers to Improve Malaria Case
Management in Children under Five In Nigeria
George Greer, BASICS II, U.S.A.
6. Using New Technology to Increase Productivity: The Role of PDAs in in the
Tanzania Quality Assurance Program
Arin Speed, Management Sciences for Health/CPM, U.S.A., and Mwemezi Ngemera,
Tanzanian Food and Drug Authority, Tanzania
3:30�4:00 p.m.
Coffee/Tea break
4:00�6:00 p.m.
Afternoon session #2
Small group discussions
Pharmaceutical Procurement
Group A � Room: Marquee 1
Group B � Room: Marquee 2
Group C � Room: Tradewinds
Group D � Room: Kivukoni 1-3
Human Resources for the Pharmaceutical Sector
Group A � Room: Ruvu
Group B � Room: Kivukoni 4
Group C � Room: Marquee 3
Group D � Room: Marquee 4
DAY 3�December 12, 2003
All Day
Posters and electronic demos on display
Author coverage during breaks
8:30�10:15 a.m.
Morning session #1
Parallel track sessions
Pharmaceutical Product Quality Assurance � Room: Kivukoni 1-3 (Simultaneous
French translation available)
Co-moderators: Dr. N. B. Chukilizo and Marthe Everard
1. Quality Assurance in Practice: Product Quality Standards and
Bioequivalence Issues
Thomas Layloff, Management Sciences for Health/SEAM, U.S.A.
2. Registration, Inspection, and Testing: How to Prioritize
Souly Phanouvong, USP. U.S.A.
3. GMP Compliant: To Be or Not to Be? Relative Risks of Noncompliance
a. Regulatory Perspective
Charles Kandie, WHO/Kenya
b. Procurement Perspective
Henk den Besten, International Dispensary Association, The Netherlands
4. Minilabs as a Component of Quality Monitoring: Experiences and
Methodological Issues
Zera Msuya, Food and Drugs Authority, Tanzania
Pharmaceutical Product Prices � Room: Kivukoni 4
Co-moderators: Zachary Berege and Abayneh Desta
1. Policies That Promote Fair Pricing of Pharmaceuticals
Anthony So, The Rockefeller Foundation, U.S.A.
2. Implementation of the Doha Declaration on TRIPS/Public Health: Overview
of Recent Developments and Actions Needed to Ensure That the Declaration
Impacts Procurement of Low-Priced Medicines
Sisule Musungu, Programme on International Trade & Development, South
Centre, Geneva, Switzerland
3. Medicines: The Price People Pay
Margaret Ewen, HAI, The Netherlands
4. A New Approach to Measuring Drug Prices: Results of the WHO/HAI Drug
Pricing Project�s South African Pilot Study
Aarti Patel, South Africa
5. Factors Contributing to the Pricing of Pharmaceuticals in Tanzania
Mhina S. Chambuso, Muhimbili University College of Health Sciences, Tanzania
10:15�10:45 a.m.
Coffee/Tea break
10:45 a.m.�12:30 p.m.
Morning session #2
Small group discussions
Pharmaceutical Product Quality Assurance:
Group A � Room: Marquee 1
Group B � Room: Marquee 2
Group C � Room: Tradewinds
Group D � Room: Kivukoni 1-3
Pharmaceutical Product Prices:
Group A � Room: Ruvu
Group B � Room: Kivukoni 4
Group C � Room: Marquee 3
Group D � Room: Marquee 4
12:30 p.m.�1:30 p.m.
Lunch break
1:30�3:00 p.m.
Afternoon session #1
Moderator: Dr. Omar Makame Shauri
Plenary presentations � Room: Kivukoni 1-3 (Simultaneous French translation
available)
� Reports of parallel track topic discussion group
1. Pharmaceutical Management and Supply Systems
2. Rational Use of Medicines
3. Pharmaceutical Procurement
4. Human Resources for the Pharmaceutical Sector
� Discussion
3:00�3:15 p.m.
Coffee/Tea break
3:15�4:30 p.m.
Afternoon session #2
Moderator: Dr. Omar Makame Shauri
Plenary presentations � Room: Kivukoni 1-3 (Simultaneous French translation
available)
� Reports of parallel track topic discussion groups (continued)
5. Pharmaceutical Product Quality Assurance
6. Pharmaceutical Product Prices
� Discussion
� Remarks by Representative from Ghana
� Closing address
Honorable Anna Margareth Abdallah, Minister of Health, United Republic of
Tanzania
� Closing remarks
Keith Johnson, Director, SEAM Program, Management Sciences for Health,
U.S.A.